New Delhi: Homegrown pharma majors Sun Pharma, Cipla, Hetero and Torrent on Tuesday announced plans to market their versions of antiviral drug Molnupiravir to treat high-risk adult patients with COVID-19 across India shortly. The companies have received approvals from the Drugs Controller General of India (DCGI) to manufacture and market their versions of anti-Covid pill Molnupiravir […]
